These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1397206)

  • 1. In vitro sensitivity of Penicillium marneffei and Pythium insidiosum to various antifungal agents.
    Sekhon AS; Padhye AA; Garg AK
    Eur J Epidemiol; 1992 May; 8(3):427-32. PubMed ID: 1397206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antifungal activity of the new triazole D0870 against Penicillium marneffei compared with that of amphotericin B, fluconazole, itraconazole, miconazole and flucytosine.
    Boon-Long J; Mekha N; Poonwan N; Kusum M; Mikami Y; Yazawa K; Konyama K
    Mycoses; 1996; 39(11-12):453-6. PubMed ID: 9145003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimens.
    Supparatpinyo K; Nelson KE; Merz WG; Breslin BJ; Cooper CR; Kamwan C; Sirisanthana T
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2407-11. PubMed ID: 8285625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro interactions of micafungin with amphotericin B, itraconazole or fluconazole against the pathogenic phase of Penicillium marneffei.
    Cao C; Liu W; Li R; Wan Z; Qiao J
    J Antimicrob Chemother; 2009 Feb; 63(2):340-2. PubMed ID: 19054803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antifungal-drug susceptibilities of mycelial and yeast forms of Penicillium marneffei isolates in Cambodia.
    Sar B; Boy S; Keo C; Ngeth CC; Prak N; Vann M; Monchy D; Sarthou JL
    J Clin Microbiol; 2006 Nov; 44(11):4208-10. PubMed ID: 16971649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibility of mycelial and yeast forms of Penicillium marneffei to amphotericin B, fluconazole, 5-fluorocytosine and itraconazole.
    Sekhon AS; Garg AK; Padhye AA; Hamir Z
    Eur J Epidemiol; 1993 Sep; 9(5):553-8. PubMed ID: 8307142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro sensitivity of medically significant Fusarium species to various antimycotics.
    Sekhon AS; Padhye AA; Garg AK; Ahmad H; Moledina N
    Chemotherapy; 1994; 40(4):239-44. PubMed ID: 8082411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antifungal drug susceptibilities of Penicillium marneffei from China.
    Liu D; Liang L; Chen J
    J Infect Chemother; 2013 Aug; 19(4):776-8. PubMed ID: 23104584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of the Sterol Biosynthetic Pathway of Pythium insidiosum and Related Oomycetes Contributes to Antifungal Drug Resistance.
    Lerksuthirat T; Sangcakul A; Lohnoo T; Yingyong W; Rujirawat T; Krajaejun T
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28115356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro activity of terbinafine combined with caspofungin and azoles against Pythium insidiosum.
    Cavalheiro AS; Maboni G; de Azevedo MI; Argenta JS; Pereira DI; Spader TB; Alves SH; Santurio JM
    Antimicrob Agents Chemother; 2009 May; 53(5):2136-8. PubMed ID: 19289531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penicillium marneffei: types and drug susceptibility.
    Imwidthaya P; Thipsuvan K; Chaiprasert A; Danchaivijitra S; Sutthent R; Jearanaisilavong J
    Mycopathologia; 2001; 149(3):109-15. PubMed ID: 11307592
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Worasilchai N; Chindamporn A; Plongla R; Torvorapanit P; Manothummetha K; Chuleerarux N; Permpalung N
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro synergism observed with azithromycin, clarithromycin, minocycline, or tigecycline in association with antifungal agents against Pythium insidiosum.
    Jesus FP; Ferreiro L; Loreto ÉS; Pilotto MB; Ludwig A; Bizzi K; Tondolo JS; Zanette RA; Alves SH; Santurio JM
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5621-5. PubMed ID: 25001300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of carvacrol and thymol combined with antifungals or antibacterials against Pythium insidiosum.
    Jesus FP; Ferreiro L; Bizzi KS; Loreto ÉS; Pilotto MB; Ludwig A; Alves SH; Zanette RA; Santurio JM
    J Mycol Med; 2015 Jun; 25(2):e89-93. PubMed ID: 25639921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of amphotericin B, hamycin and their novel water-soluble compounds against pathogenic yeasts.
    Sekhon AS; Padhye AA; Garg AK; Hamir Z
    Chemotherapy; 1992; 38(5):297-302. PubMed ID: 1286573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of antifungals in combination with essential oils against the oomycete Pythium insidiosum.
    Valente JS; Fonseca AO; Denardi LB; Dal Ben VS; Maia Filho FS; Zambrano CG; Braga CQ; Alves SH; Botton SA; Brayer Pereira DI
    J Appl Microbiol; 2016 Oct; 121(4):998-1003. PubMed ID: 27417677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro interactions of calcineurin inhibitors with conventional antifungal agents against the yeast form of Penicillium marneffei.
    Mo D; Li X; Wei L; Sun C; Liang H; Cao C
    Mycopathologia; 2014 Oct; 178(3-4):217-20. PubMed ID: 25052248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
    Martín E; Parras P; Lozano MC
    Chemotherapy; 1992; 38(5):335-9. PubMed ID: 1337508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candida glabrata: in vitro susceptibility of 84 isolates to eight antifungal agents.
    Arias A; Arévalo MP; Andreu A; Rodríguez C; Sierra A
    Chemotherapy; 1996; 42(2):107-11. PubMed ID: 8697885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibility of zoospores and hyphae of Pythium insidiosum to antifungals.
    Fonseca AO; Pereira DI; Maia Filho FS; Osório LG; Maroneze BP; Valente JS; Pötter L; Meireles MC
    J Antimicrob Chemother; 2014 Jun; 69(6):1564-7. PubMed ID: 24521855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.